Gufic Biosciences Ltd (GUFI)

Currency in INR
385.05
-1.95(-0.50%)
Closed·
GUFI Scorecard
Full Analysis
Trading at a high earnings multiple
GUFI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
378.90393.75
52 wk Range
285.00501.10
Key Statistics
Bid/Ask
380.30 / 395.00
Prev. Close
387
Open
393.75
Day's Range
378.9-393.75
52 wk Range
285-501.1
Volume
4.75K
Average Volume (3m)
4.69K
1-Year Change
10.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GUFI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Gufic Biosciences Ltd Company Profile

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Employees
1491
Market
India

Compare GUFI to Peers and Sector

Metrics to compare
GUFI
Peers
Sector
Relationship
P/E Ratio
55.4x35.8x−0.5x
PEG Ratio
−2.710.270.00
Price/Book
6.4x3.6x2.6x
Price / LTM Sales
4.7x4.2x3.2x
Upside (Analyst Target)
-6.3%41.6%
Fair Value Upside
Unlock−1.0%6.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.95%
Dividend Yield
0.03%
Industry Median 0.74%
Annualised payout
0.10
Paid annually
5-Years Growth
+14.87%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.77 / --
Revenue / Forecast
2.05B / --
EPS Revisions
Last 90 days

GUFI Income Statement

People Also Watch

3,622.90
TORP
+0.53%
941.25
NATP
-2.73%
1,490.30
CHLA
-0.90%
2,703.80
MBFL
+3.00%

FAQ

What Stock Exchange Does Gufic Biosciences Ltd Trade On?

Gufic Biosciences Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Gufic Biosciences Ltd?

The stock symbol for Gufic Biosciences Ltd is "GUFI."

What Is the Gufic Biosciences Ltd Market Cap?

As of today, Gufic Biosciences Ltd market cap is 38.61B.

What Is Gufic Biosciences Ltd's Earnings Per Share (TTM)?

The Gufic Biosciences Ltd EPS (TTM) is 6.95.

From a Technical Analysis Perspective, Is GUFI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Gufic Biosciences Ltd Stock Split?

Gufic Biosciences Ltd has split 1 times.

How Many Employees Does Gufic Biosciences Ltd Have?

Gufic Biosciences Ltd has 1491 employees.

What is the current trading status of Gufic Biosciences Ltd (GUFI)?

As of 28 Jul 2025, Gufic Biosciences Ltd (GUFI) is trading at a price of 385.05, with a previous close of 387.00. The stock has fluctuated within a day range of 378.90 to 393.75, while its 52-week range spans from 285.00 to 501.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.